The Vagus Nerve:
What Science Now Knows
and Isn't Saying Enough

What exactly is the vagus nerve?

The vagus nerve is the longest cranial nerve in the human body — the tenth of twelve pairs — and its Latin name means "wandering." That name is apt. It meanders from the brainstem down through the neck, chest, and abdomen, branching into nearly every major organ along the way: heart, lungs, liver, spleen, kidneys, and almost the entire digestive tract.

It is the primary highway of the parasympathetic nervous system — the branch responsible for the body's "rest and digest" state. But calling it a simple calming nerve undersells it dramatically. It is a two-way communication system: roughly 80% of its fibers carry information to the brain (afferent), while only about 20% carry signals from the brain to the organs (efferent). This means your body is constantly reporting upward, shaping how you feel, think, and respond to the world.

There are two vagus nerves — one on each side of the body — and emerging research suggests they are not functionally identical. The right vagus nerve has stronger connections to the sinoatrial node of the heart and plays a distinct role in cardiac regulation. This asymmetry is increasingly important in clinical research.

The role it plays across body systems

Cardiovascular regulation

The vagus nerve continuously modulates heart rate through what is called "vagal tone" — a measure of how actively it is applying a brake to the heart's natural pacemaker. High vagal tone is associated with lower resting heart rate, better heart rate variability (HRV), and generally stronger cardiovascular health. Loss of vagal tone correlates with increased cardiac risk.

The inflammatory reflex

One of the most paradigm-shifting discoveries of the past two decades is that the vagus nerve directly suppresses inflammation. When immune cells in the spleen and gut detect inflammatory signals, the vagus nerve can transmit inhibitory signals that reduce cytokine production — specifically tumor necrosis factor (TNF-α), interleukin-1β (IL-1β), and other inflammatory mediators. This circuit is now called the "inflammatory reflex," and it has become the foundation of an entirely new field: bioelectronic medicine.

Gut-brain communication

The vagus nerve is the anatomical substrate of the gut-brain axis. It carries signals from the enteric nervous system (the "second brain" lining the gut) to the brainstem, relaying information about microbiome metabolites, nutrient status, gut motility, and even emotional states arising in the gut. Research has confirmed that the vagus nerve can detect metabolites produced by gut bacteria and transmit this information to the brain, influencing mood, behavior, and cognition.

Respiratory and swallowing control

The vagus nerve controls the muscles of the soft palate, pharynx, and larynx. It is essential for swallowing, speaking, and the gag reflex, and it plays a role in coordinating breathing rhythm with heart rate — a phenomenon called respiratory sinus arrhythmia (RSA), a key marker of autonomic health.

Metabolic and hormonal signaling

Vagal afferents detect gut hormones such as cholecystokinin (CCK), leptin, and ghrelin, transmitting satiety and hunger signals to the hypothalamus. Disruption of this pathway has been implicated in obesity and metabolic syndrome, and it is one reason GLP-1 receptor agonists (like semaglutide) interact with vagal pathways to suppress appetite.

New discoveries reshaping the science

What's being talked about

In mainstream wellness and even in clinical circles, a few vagus nerve topics have achieved near-ubiquity:

Vagal toning practices

Cold water exposure, humming, gargling, deep diaphragmatic breathing, and yoga are now widely discussed as methods to increase vagal tone. Some of these have modest but real supporting evidence — particularly slow, deep breathing (around 6 breaths per minute), which reliably increases HRV and RSA in controlled studies.

Bioelectronic medicine

Dr. Kevin Tracey's work — consolidated in his 2025 book The Great Nerve — has put vagus nerve stimulation into the mainstream medical conversation. The technology is moving fast: an implantable device for rheumatoid arthritis is now on the market in some jurisdictions, and ear-worn non-invasive stimulators are in trials for conditions ranging from depression to IBS.

The gut-brain axis

The role of the vagus nerve in the gut-brain axis is well-covered in nutrition and mental health media. The connection between gut microbiome health and mood — mediated in part through vagal signaling — has reached mainstream awareness, if not always with scientific precision.

HRV as a wellness metric

Wearable devices have made heart rate variability tracking mainstream. HRV is the most accessible proxy for vagal tone available to consumers, and its correlation with recovery, stress resilience, and cardiovascular health is well-supported.

What isn't being said enough

Chronic illness and vagal dysfunction

Conditions like fibromyalgia, chronic fatigue syndrome (ME/CFS), long COVID, and POTS are increasingly understood to involve autonomic nervous system dysregulation — with vagal dysfunction as a probable contributor. Yet most patients with these conditions are never evaluated for vagal tone or autonomic function. The lag between the research and clinical practice here is significant.

Trauma stored in the nervous system

Research clearly links PTSD and chronic stress to reduced vagal tone. Patients with PTSD show measurably different autonomic profiles — including suppressed HRV and reduced parasympathetic activity — compared to controls. The body is not just psychologically affected by trauma; the vagus nerve is physiologically altered. This has major implications for treatment, yet most trauma therapy still operates without considering autonomic restoration as a clinical goal.

The right vagus vs. the left

Most discussions treat the vagus nerve as a single entity, but right and left vagus nerves have distinct cardiac and immunological functions. The December 2025 Sant'Anna study specifically identified the right vagus as the critical pathway for cardiac aging protection. Clinical and consumer discussions rarely engage with this laterality.

Sex differences in vagal function

Women and men show different vagal profiles, HRV patterns, and responses to VNS. The University of Oklahoma's osteoarthritis research found that vagus nerve stimulation reduced central pain sensitization primarily in female mice. These sex-specific differences are almost entirely absent from popular coverage and insufficiently represented in clinical trials.

The vagus nerve and cancer immunosurveillance

Early-stage research is exploring whether vagal signaling influences the immune system's ability to surveil and respond to tumor cells. Dr. Tracey's work has noted connections between inflammatory dysfunction and cancer risk. This research is too preliminary to make clinical claims, but it is almost entirely absent from public discourse given its potential importance.

Polyvagal theory vs. the actual science

Polyvagal Theory (PVT) has become enormously popular in therapy, trauma, and wellness communities — but a 2025 evaluation by 38 neuroscientists found that several of its foundational anatomical claims, particularly around "dorsal vagal shutdown," are not supported by current evidence. This is not a reason to abandon vagal-regulation practices, which have independent empirical support. But it is a reason to be more precise when speaking about mechanisms, and to resist conflating a useful clinical framework with established neuroscience.

Symptoms of vagus nerve dysfunction

Vagal dysfunction — sometimes called vagal neuropathy or vagopathy — can result from physical nerve damage, chronic inflammation, autoimmune attack, or persistent dysregulation of nerve signaling. Because the vagus nerve touches so many systems, its dysfunction is often diffuse and difficult to attribute to a single cause.

Low vagal tone is increasingly recognized as a transdiagnostic risk factor — appearing across depression, PTSD, inflammatory disease, metabolic syndrome, and cardiovascular conditions. Some researchers argue it deserves recognition as a clinical biomarker in its own right, not merely a secondary feature of other diagnoses.

The science and what it actually supports

Vagus nerve stimulation: what's FDA-cleared and what's experimental

Implantable VNS has been FDA-cleared for treatment-resistant epilepsy since 1997, and for treatment-resistant depression since 2005. Non-invasive transcutaneous VNS (delivered through the ear or neck) has received clearance for cluster headaches and migraine. As of 2025–2026, clinical trials are actively underway for rheumatoid arthritis, Crohn's disease, POTS, atrial fibrillation, osteoarthritis, and long COVID. Outside cleared indications, consumer-marketed VNS devices operate in a regulatory gray area with varying levels of supporting evidence.

Heart rate variability as a proxy measure

HRV — the variation in time between heartbeats — is the most studied non-invasive measure of vagal tone. Higher HRV in resting conditions correlates with better cardiovascular health, emotional regulation, and resilience to stress. Meta-analyses confirm that practices including slow breathing (4–6 breaths/minute), aerobic exercise, meditation, and biofeedback reliably improve HRV in the short term. Whether sustained improvements translate to long-term health outcomes is still under investigation.

The inflammatory reflex: mechanism and clinical translation

The pathway from vagal stimulation to immune suppression is now well-characterized: vagal efferents activate the spleen via the celiac ganglion and splenic nerve; splenic acetylcholine-producing T cells then suppress macrophage TNF production. In clinical trials for rheumatoid arthritis, this pathway has produced measurable reductions in inflammatory markers (CRP, ESR, DAS28 scores) comparable to some pharmacological treatments — with the advantage of fewer systemic side effects.

Depression and the microbiota-gut-brain axis

Research published in multiple peer-reviewed journals confirms that gut microbiome dysbiosis is associated with depression, and that vagal afferents are a key route by which gut-derived neurotransmitters (serotonin, GABA) and microbial metabolites (short-chain fatty acids) reach the brain. Studies in rodents following vagotomy (surgical severing of the vagus nerve) show that many of the mood-modifying effects of probiotics disappear when the vagus is cut — directly implicating the nerve as the transmission route.

What remains genuinely uncertain

The optimal parameters for VNS (frequency, intensity, duration, waveform) are not standardized across conditions. The long-term effects of non-invasive consumer-grade stimulators are not well studied. The specific mechanisms linking vagal tone to cognitive function, social behavior, and subjective wellbeing are established in correlation but not always in causation. And the polyvagal model, while clinically useful, requires more rigorous anatomical verification before its more specific mechanistic claims can be stated as fact.